Regis Corp. (RGS) Financials Nov 20, 2014, 4:33
Regis Corp. (RGS) Financials Nov 20, 2014, 4:33 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Regis Corp.
Fiscal year is July-June. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 2.36B 2.33B 2.27B 2.02B 1.89B
Cost of Goods Sold (COGS) incl. D&A 1.59B 1.57B 1.55B 1.45B 1.38B
COGS excluding D&A 1.48B 1.46B 1.43B 1.36B 1.3B
Depreciation & Amortization Expense 108.76M 105.11M 118.07M 84.02M 81.41M
Depreciation 98.89M - 101.7M 82.22M 79.71M
Amortization of Intangibles 9.87M - 16.37M 1.8M 1.7M
Gross Income 770.73M 760.24M 722.17M 571.98M 514.17M
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 636.09M 682.14M 643.38M 551.46M 494.9M
Research & Development 0 0 0 0 0
Other SG&A 636.09M 682.14M 643.38M 551.46M 494.9M
Other Operating Expense 0 0 0 0 0
Unusual Expense 37.42M 73.54M 146.22M 28.2M 53.27M
EBIT after Unusual Expense (37.42M) (73.54M) (146.22M) (28.2M) (53.27M)
Non Operating Income/Expense 9.71M 3.3M 4.84M 55.37M 1.95M
Non-Operating Interest Income 700,000 700,000 500,000 0 0
Equity in Affiliates (Pretax) - 200,000 0 - -
Interest Expense 54.41M 34.39M 28.25M 37.59M 22.29M
Gross Interest Expense 54.41M 34.39M 28.25M 37.59M 22.29M
Interest Capitalized - - - - -
Pretax Income 53.21M (25.63M) (90.33M) 10.1M (54.33M)
Income Tax 25.58M (9.5M) (5.28M) (10.02M) 71.13M
Income Tax - Current Domestic 5.58M 3.66M 6.49M (21.05M) 1.46M
Income Tax - Current Foreign 14.88M 1.56M 2.4M 707,000 890,000
Income Tax - Deferred Domestic 4.01M (17.88M) (13.98M) 10.41M 67.99M
Income Tax - Deferred Foreign 1.11M 3.17M (187,000) (83,000) 787,000
Income Tax Credits 0 0 0 0 -
Equity in Affiliates 11.94M 7.23M (30.04M) (15.96M) (11.62M)
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 39.58M (8.91M) (115.09M) 4.17M (137.08M)
Minority Interest Expense 0 0 100,000 0 0
Net Income 39.58M (8.91M) (115.19M) 4.17M (137.08M)
Extraordinaries & Discontinued Operations 3.16M 0 1.1M 25.03M 1.35M
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations 3.16M 0 1.1M 25.03M 1.35M
Net Income After Extraordinaries 42.74M (8.91M) (114.09M) 29.19M (135.73M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 39.58M (8.91M) (115.19M) 4.17M (137.08M)
EPS (Basic) 0.77 (0.16) (2.00) 0.51 (2.40)
Basic Shares Outstanding 55.81M 56.7M 57.14M 56.7M 56.48M
EPS (Diluted) 0.64 (0.16) (2.00) 0.51 (2.40)
Diluted Shares Outstanding 66.75M 56.7M 57.14M 56.85M 56.48M
EBITDA 243.4M 183.21M 196.87M 104.54M 100.68M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Run Like No Other I’ll bet you’ve heard it all when it comes to races—winding city marathons, grueling ultras with rough terrain, and everything in between. But a world championship on treadmills? Now that's a fresh spin! October 23rd, 2026 is when the RUN X™ World Treadmill Championship kicks off, stretching out across the planet in 400 fitness centres...
Continue Reading
MSG Rangers Takes Center Ice—In the Market Here we go—MSG Rangers (NYSE: MSGR) is sliding into the S&P SmallCap 600 like a puck on fresh ice, ready to switch places with Arbor Realty Trust (NYSE: ABR) come October 27. Now, that's not just a game changer for MSGR, but also throws some shuffle onto the board for investors in these organizations. We've got Madison Square...
Continue Reading
An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...
Continue Reading
A New Flavor Adventure Lands on Aisles Alright, folks, nothing quite spices up a mundane snack session like a new sauce from a brand with serious street cred. Tajín's latest brainchild, the Twist Chamoy Sauce, just hit a retailer near you. It's promising to take your tastebuds on a rollercoaster ride—no ticket needed, just a generous pour over whatever munchies you're...
Continue Reading
Grace in the Spotlight: A Game-Changer in Virtual Healthcare If you're tired of healthcare tech making big promises and delivering little, this might pique your interest. Lyric Health has rolled out Grace, a multimodal AI addition to their Virtual Care Operating System. This isn’t your run-of-the-mill chatbot — it’s a blend of proactive health monitoring,...
Continue Reading
Saab's Stellar Q3 Performance If there’s one picture capturing the essence of Saab’s third quarter in 2026, it's one brimming with contracts, cash, and sheer growth. They’re racking up tangible wins left and right, and if you're an investor who loves numbers doing a solid 30.6% high jump, Saab's buzzing red-hot. Key Contracts Putting Saab in the Spotlight The very...
Continue Reading
Ademi LLP Puts TTMI in the Spotlight If you blinked, you might have missed it, but TTM Technologies, listed on NASDAQ as TTMI, has taken a nosedive recently—shedding over 25% of its stock value in what’s proving to be a hot mess for its shareholders. The cherry on top? Ademi LLP is rolling up its sleeves for an investigation into what looks like a tangled web of...
Continue Reading
Breaking Down the US$855 Million Payout Just when you think you’ve got the insurance landscape figured out, FM spins the wheel with a US$855 million resilience credit, all thanks to its mutual structure and healthy results. Let’s unpack this hefty premium offset, shall we? A Second Year of Solid Savings This isn’t FM’s first rodeo. We're talking about a 10%...
Continue Reading
A Mural Tribute to Country Music Roots Forget about skyscrapers and bustling metropolises; sometimes, it's about bringing a bit of soul back to the heartland. That's precisely what the unveiling of the "Wildflowers and Wild Horses" mural in Philadelphia, Mississippi, did. Lainey Wilson and Marty Stuart's Vision Partners in crime — or, more fittingly, in country —...
Continue Reading
Riding the Wave of Sustainable Coatings Who'd have thought we'd be chatting about wood coatings making such a splash? Turns out, this unsung hero of the materials world is gearing up for some serious growth, with the market projected to hit a crisp $33.34 billion by 2032. That's a decent jump from where it stands today, and it's all thanks to the shift towards...
Continue Reading
Top 5 Most Recently Viewed Articles
Nasuni Empowers Major Brands for Holiday Success Household brands are continually enhancing their competitiveness, driving customer growth, and boosting productivity with Nasuni's cutting-edge hybrid cloud solutions. As the holiday season approaches, the demands on retailers increase significantly. Nasuni, an enterprise data platform known for its robust capabilities in...
Continue Reading
JDE Peet’s Employee Incentive Plans: Recent Grants and Transfers JDE Peet’s N.V. (EURONEXT: JDEP) has made significant strides in its approach to employee incentives, emphasizing its dedication to valuing its workforce. In a recent announcement, the company outlined its actions regarding share grants as part of its ongoing employee incentive plans. These initiatives...
Continue Reading
Liongard Appoints Brook Lee as VP to Enhance MSP Engagement Liongard, a leading name in Attack Surface Management catering to Managed Service Providers (MSPs) and IT Service Providers, is excited to announce the appointment of Brook Lee as its new Vice President of Community and Channel. With more than 15 years of experience within the MSP industry, Brook brings a wealth...
Continue Reading
Honoring Dr. Rachel L. Ivory for Her Educational Contributions Featured prominently as a Pinnacle Professional Member, Dr. Rachel L. Ivory stands out for her substantial contributions to the fields of education and literature. Her dedication has led her to be recognized by many for her impactful work, especially in leadership training, publishing, and community...
Continue Reading
Results Revealed: A Game Changer in Cholangiocarcinoma Treatment Zenocutuzumab is stirring the pot in cancer treatment with some potentially ground-breaking results recently unveiled. Partner Therapeutics, a biotech player with skin in the oncology game, has revealed results from the eNRGy trial. These findings have not only turned heads but also led to U.S. FDA approval...
Continue Reading